H.C. Wainwright analyst Emily Bodnar downgraded Agenus Inc. (NASDAQ: AGEN) from Buy to Neutral, PT $9The analyst comments "FDA advises ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE